Renal Business Today

Journal Of The American Society Of Nephrology (JASN)

Damage to Blood Vessel Lining May Account for Kidney Failure Patients' Heart Risks

WASHINGTON—Individuals with kidney failure often develop heart problems, but it’s not clear why. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides evidence that their kidneys’ inability to excrete waste products in ...More
October 19, 2012
Posted in News, Clinical & Pharma
New Target for Treating Diabetic Kidney Disease

WASHINGTON—Researchers have discovered a new therapeutic target for diabetic nephropathy, the leading cause of kidney failure. The findings, appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), could help protect the kidney health of ...More
October 19, 2012
Posted in News, Clinical & Pharma
Single Gene Variant in Donors May Affect Survival of Transplanted Kidneys

WASHINGTON—A single genetic variant in kidney donors' cells may help determine whether their transplanted organs will survive long term, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings provide new ...More
October 15, 2012
Posted in News, Clinical & Pharma
New Blood Test Detects Potentially Deadly Calcium Deposits

WASHINGTON—A new test could help identify and treat individuals at risk of developing potentially deadly calcium deposits in their tissues and blood vessels, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). ...More
September 12, 2012
Posted in News, Clinical & Pharma
Simple Blood Tests Detect Autoimmune Kidney Disease, Help Predict Prognosis

WASHINGTON—Simple blood tests could help physicians decide which patients with a particular autoimmune kidney disease can forgo potentially toxic medications and which need to be treated, according to a study appearing in an upcoming issue of the Journal of the American ...More
September 7, 2012
Posted in News, Clinical & Pharma
Some Patients with Common Kidney Disease Can Skip Standard Treatments

WASHINGTON—For patients with a common kidney disease who have normal kidney function and only minor urinary abnormalities at the time of diagnosis, the long-term prognosis is excellent and no special treatments are needed, according to a study appearing in an upcoming issue ...More
September 7, 2012
Posted in News, Clinical & Pharma
Lifetime ESRD Risk Higher for Men

ALBERTA, Canada—Men have a greater lifetime risk for end-stage renal disease (ESRD) than women, according to a Canadian study, reported Renal and Urology News. ...More
August 21, 2012
Posted in News, Clinical & Pharma
What's Your Lifetime Risk of Developing Kidney Failure?

WASHINGTON—How likely are middle-aged adults to develop kidney failure during their lifetime? A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides some insights, which may be used to help set priorities related to ...More
August 17, 2012
Posted in News, Clinical & Pharma
New Drug Shows Promise for PKD

SANTA BARBARA, Calif.—Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease —although it will be a few years before it becomes available for clinical testing. ...More
August 3, 2012
Posted in News, Clinical & Pharma
Safety and Effectiveness of Common Kidney Disease Drugs Questioned

WASHINGTON—Drugs commonly prescribed to patients with chronic kidney disease (CKD) may not be as strongly effective as once thought, and may cause unexpected harm to blood vessels, according to a study appearing in an upcoming issue of the Journal of the American Society of ...More
July 20, 2012
Posted in News, Clinical & Pharma

featured links

HOT TOPICS